Steven E. McNulty

Active 1997–2023

36
Papers
20,192
Citations
34
h-index
36
i10-index

Citations

Citations per year for Steven E. McNulty1992: 1 citations1996: 4 citations1997: 1 citations1998: 3 citations1999: 9 citations2000: 4 citations2001: 20 citations2002: 9 citations2003: 16 citations2004: 11 citations2005: 56 citations2006: 104 citations2007: 72 citations2008: 87 citations2009: 91 citations2010: 102 citations2011: 88 citations2012: 114 citations2013: 122 citations2014: 137 citations2015: 148 citations2016: 159 citations2017: 161 citations2018: 134 citations2019: 568 citations2020: 570 citations2021: 546 citations2022: 466 citations2023: 379 citations2024: 601 citations2025: 340 citations2026: 5 citations1993–1995: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,223 citing papers, 24.3% of this breakdownUnited Kingdom: 640 citing papers, 7% of this breakdownItaly: 604 citing papers, 6.6% of this breakdownGermany: 544 citing papers, 5.9% of this breakdownCanada: 474 citing papers, 5.2% of this breakdownNetherlands: 471 citing papers, 5.2% of this breakdownFrance: 325 citing papers, 3.6% of this breakdownSpain: 255 citing papers, 2.8% of this breakdownJapan: 253 citing papers, 2.8% of this breakdownChina: 247 citing papers, 2.7% of this breakdownAustralia: 205 citing papers, 2.2% of this breakdownPoland: 196 citing papers, 2.1% of this breakdown
0%24.3%Other 29.6%

Fields

  • Medicine92.6%
  • Biochemistry, Genetics and Molecular Biology3.1%
  • Engineering1.8%
  • Nursing0.4%
  • Health Professions0.4%
  • Economics, Econometrics and Finance0.4%
  • Other1.3%

Topics

  • Heart Failure Treatment and Management13.9%
  • Cardiovascular Function and Risk Factors10.8%
  • Cardiac pacing and defibrillation studies8.2%
  • Cardiac electrophysiology and arrhythmias4.9%
  • Diabetes Treatment and Management4.3%
  • Cardiac Imaging and Diagnostics2.7%
  • Other55.2%

Coauthors

All papers

Open in search
  1. Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction

    Authors: , , , , , , , , , , , , , , - New England Journal of Medicine 2020 cited by 1,299

  2. Effects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction

    Authors: , , , , , , , , , , , , , , - JAMA 2016 cited by 677

  3. Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure

    Authors: , , , , , , , , , , , , , , , , - New England Journal of Medicine 2005 cited by 6,526

  4. Diuretic Strategies in Patients with Acute Decompensated Heart Failure

    Authors: , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2011 cited by 1,692

  5. Quality of Life in Heart Failure with Preserved Ejection Fraction: Importance of Obesity, Functional Capacity, and Physical Inactivity

    Authors: , , , , , , , , , , , - European Journal of Heart Failure 2020 cited by 237

  6. Ultrafiltration in Decompensated Heart Failure with Cardiorenal Syndrome

    Authors: , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2012 cited by 984

  7. Effect of Phosphodiesterase-5 Inhibition on Exercise Capacity and Clinical Status in Heart Failure With Preserved Ejection Fraction

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , for the RELAX Trial - JAMA 2013 cited by 1,130

  8. Characterization of the Obese Phenotype of Heart Failure With Preserved Ejection Fraction: A RELAX Trial Ancillary Study

    Authors: , , , , , , , , , , , , , - Mayo Clinic Proceedings 2019 cited by 138

  9. Isosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction

    Authors: , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2015 cited by 538

  10. Efficacy and Safety of Spironolactone in Acute Heart Failure

    Authors: , , , , , , , , , , , , , , , , - JAMA Cardiology 2017 cited by 306

  11. Effect of Oral Iron Repletion on Exercise Capacity in Patients With Heart Failure With Reduced Ejection Fraction and Iron Deficiency

    Authors: , , , , , , , , , , , , , , , , , - JAMA 2017 cited by 452

  12. Relief and Recurrence of Congestion During and After Hospitalization for Acute Heart Failure

    Authors: , , , , , , , , , , , , , , - Circulation Heart Failure 2015 cited by 328

  13. Effect of Treatment With Sacubitril/Valsartan in Patients With Advanced Heart Failure and Reduced Ejection Fraction

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gina Ciezkowski, Glenda Herrera, Hirsch Mehta, Rosemarie Delucca, Sanjay Doddamani, Manreet Kanwar, B. Thomas, Laurie Machen, J. Kim, Athas Christina, Brent C. Lampert, Cindy Fontenelle, Clement Eiswirth, Julie Williams, Darlene Rock, Gregory F. Egnaczyk, Enya Rentas-Sherman, Deborah Barr, Arvind Bhimaraj, Adrianna Damato, Christine Calayo, John M. Herre, JoAnn Lindenfeld, Amanda Carroll, Mary Gordon, Mary Keebler, Bandaa Setliff, Sanjeev Gulati, K Winkler, Laura Curtin, Carly Ohmart, John Halvorson, James O. Mudd, S. Albert Camacho, Maryse Palardy, Neha Shah, Kristina Picardi, Arun Krishnamoorthy, Adrienne Maximin, Douglas Horstmanshof, Beverly Seiler, Zi J. Xu, S. Mersola, E. Kransdorf, W.H. Wilson Tang, T. Fonk, Eiran Z. Gorodeski, Guilherme H. Oliveira, Terrence Semenec, Nadine Norton, Julie Nichols, Peter Leo, Mark E. Dunlap, G. Michael Felker, Lacey D. Taylor, Mary Sheehan, Sharon Levine, Diane Cocca-Spofford, Liana Brooks, Thomas F. Cunningham, Nancy Acker, Susan Milbrandt, Janet Gatzke, Víctor G. Dávila‐Román, Anne Dirks, Karen Bult, Elizabeth Weber, Mary Lesko, Deana Mikhalkova, Kathleen Fitzgerald and 19 more - JAMA Cardiology 2021 cited by 175

  14. Cardiovascular Phenotype in HFpEF Patients With or Without Diabetes

    Authors: , , , , , , , , , , - Journal of the American College of Cardiology 2014 cited by 210

  15. Effect of Inorganic Nitrite vs Placebo on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection Fraction

    Authors: , , , , , , , , , , , , , , , , , , , , - JAMA 2018 cited by 258

  16. Low-Dose Dopamine or Low-Dose Nesiritide in Acute Heart Failure With Renal Dysfunction

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Monica Shah, Adrian F. Hernandez, Eugene Braunwald, Margaret M. Redfield - JAMA 2013 cited by 501

  17. Abatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With COVID-19 Pneumonia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Luis Parra-Rodriguez, Tatyana Der, Kate Willsey, Jun Wen, A Silverstein, Sean M. O’Brien, Hussein R. Al‐Khalidi, Michael A. Maldonado, Richard Melsheimer, William Ferguson, Steven E. McNulty, Pearl Zakroysky, Susan Halabi, Daniel K. Benjamin, Sandra Butler, Jane C. Atkinson, Stacey J. Adam, Soju Chang, Lisa M. LaVange, Michael A. Proschan, Samuel A. Bozzette, William G. Powderly, ACTIV-1 IM Study Group Members, Mihir Patel, Arun J. Sanyal, Jason Green, Huimin Wu, Benjamin P. Linas, Philip Grant, Vivek Iyer, Otto O. Yang, Bindu Balani, Sam Parnia, Ryan K Dare, Caryn G. Morse, Estelle S. Harris, Glenn Wortmann, Nicholas S. Hill, Shama Patel, Julia Garcia‐Diaz, Suman Thapamager, Megan Devine, Christine M. Bojanowski, Barry Meisenberg, Gailen D. Marshall, Dima Dandachi, Arick P. Sabin, Anthony Breemo, Suman Sinha, Christopher H. Goss, Rebecca Reece, Arlette Aouad, Seth Glassman, Peter E. Morris, Bela Patel, Fatimah Bello, Juliana Cardozo Fernandes, Oscar Carbajal, L Ravera, Mozar Castro, Miguel Villegas-Chiroque, Fernando Riera, A. Casado Camacho, Claudio Stadnik, Jorge Gave, Rodrigo Biondi, Ronal Gamarra Velarde, José Cerbino Neto, J. Ditondo, Marcelo Losso and 258 more - JAMA 2023 cited by 67

  18. Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Circulation 2015 cited by 293

  19. Platelet Inhibition with Cangrelor in Patients Undergoing PCI

    Authors: , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2009 cited by 618

  20. Impaired Left Ventricular Global Longitudinal Strain in Patients with Heart Failure with Preserved Ejection Fraction: Insights from the RELAX Trial

    Authors: , , , , , , , , , , , , - European Journal of Heart Failure 2017 cited by 183

  21. Markers of Decongestion, Dyspnea Relief, and Clinical Outcomes Among Patients Hospitalized With Acute Heart Failure

    Authors: , , , , , , , , - Circulation Heart Failure 2012 cited by 181

  22. Intravenous Platelet Blockade with Cangrelor during PCI

    Authors: , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2009 cited by 643

  23. Adverse Renal Response to Decongestion in the Obese Phenotype of Heart Failure With Preserved Ejection Fraction

    Authors: , , , , , , , , , , , , , - Journal of Cardiac Failure 2019 cited by 50

  24. A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST)

    Authors: , , , , , , , , , , , , , - American Heart Journal 1997 cited by 659